Position in IDXX
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$2,105
-$141 QoQ
Shares Held
4
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,250
of 1,279 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 25%
Shared 0%
None 75%
Common Shares in IDXX Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Aspect Partners, LLC holds $182,838 across 9 Diagnostics & Research names. IDXX ranks #6 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
302 | $151,409 | |
| 2 | DHR |
Danaher Corp /De/
|
64 | $12,190 | |
| 3 | IQV |
Iqvia Holdings Inc.
|
31 | $5,988 | |
| 4 | WAT |
Waters Corp /De/
|
13 | $4,875 | |
| 5 | DGX |
Quest Diagnostics Inc
|
14 | $2,966 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
This page
|
4 | $2,105 | |
| 7 | NEO |
Neogenomics Inc
|
77 | $1,123 | |
| 8 | LH |
Labcorp Holdings Inc.
|
4 | $1,120 |
All Filings in IDXX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,105 | 4 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $2,246 | 4 | Shares | Sole | 2026-04-02 | |
| 2025-12-31 | $2,705 | 4 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,916 | 3 | Shares | Other | 2025-11-06 | |
| 2025-06-30 | $2,145 | 4 | Shares | Other | 2025-08-06 | |
| 2025-03-31 | $1,679 | 4 | Shares | Other | 2025-04-24 | |
| 2024-12-31 | $1,653 | 4 | Shares | Other | 2025-02-03 | |
| 2024-09-30 | $2,020 | 4 | Shares | Other | 2024-10-15 | |
| 2024-06-30 | $1,948 | 4 | Shares | Other | 2024-07-15 | |
| 2024-03-31 | $2,159 | 4 | Shares | Other | 2024-05-17 | |
| 2023-12-31 | $2,220 | 4 | Shares | Other | 2024-02-16 | |
| No filing history on record for this holder in this stock. | ||||||